Search clinical trials for: LEAP

Total 208 results

Indiana University
Harvard School of Public Health (HSPH); Broad Institute of MIT and Harvard; KEMRI... and other collaborators

Not yet recruiting

OPTIMAL LEAP: Optimizing Dihydroartemisinin-Piperaquine IPTsc Intervals to Advance Learning, Executive Function, Attendance, and Antimalarial Resistance Surveillance in Kenyan Schoolchildren (Optimal LEAP)

Malaria | Intermittent Preventive Treatment | Asymptomatic Malaria
Institut National de Recherche pour l'Agriculture...
European Commission

Recruiting

Protein Quality of Fava Bean and Honey Chlorella in Humans (Giant Leaps)

Protein Quality of Chlorella and Fababean Meat Analogue

France
Merck Sharp & Dohme LLC
Eisai Inc.

Terminated

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Carcinoma, Hepatocellular

Israel, United States, Australia, Brazil, Chile, China, France, Germany, Hungary, Italy, Japan, Netherlands, New Zealand, Norway, Portugal, Puerto Rico, Spain, Taiwan, Hong Kong, Ireland, Colombia, Denmark, South Korea, Thailand, Turkey... and more
Merck Sharp & Dohme LLC
Eisai Inc.

Terminated

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).

Metastatic Esophageal Squamous Cell Carcinoma

Argentina, United States, Canada, Chile, China, France, Hong Kong, Hungary, Italy, Japan, Malaysia, Romania, Singapore, South Africa, Spain, Taiwan, Ukraine, United Kingdom, Russia, Costa Rica, Denmark, Guatemala, South Korea, Thailand, Turkey (Türkiye)
Merck Sharp & Dohme LLC
Eisai Inc.

Completed

A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010) (LEAP-10)

Head and Neck Squamous Cell Carcinoma

United States, Australia, Brazil, Canada, China, France, Germany, Hungary, Italy, Japan, Peru, Spain, Taiwan, United Kingdom, Mexico, Poland, Russia, South Korea, Turkey (Türkiye)

Search clinical trials for: LEAP

This is a preview